ENCY.n (.94) Encysive Pharm-ENCY launches Thelin in Italy Monday, November 26 2007 - 5:12
ENCY $0.94 $0.18 (%23.68)
<org>Encysive Pharmaceuticals Inc. announced the commercial availability of THELIN(r)(1) 100 mg tablets in Italy for the treatment of pulmonary arterial hypertension. Encysive received European Union marketing authorization for THELIN from the European Commission in August 2006. THELIN is the first selective endothelin A receptor antagonist, and the first once-daily oral treatment available for patients with PAH.